MARKET COMPOSITE
EHC - Encompass Health Corp8:00:02 PM 5/3/2024
Price
$83.42
+ 0.54 (0.65%)
Encompass Health Corporation , based in Birmingham, Alabama, is one of the United States' largest providers of post-acute healthcare services, offering both facility-based and home-based post-acute services in 36 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies. Effective January 2, 2018, the organization changed its name to Encompass Health Corporation and its New York Stock Exchange ticker symbol from HLS to EHC. In 2003, the U.S. Securities and Exchange Commission took action against the company's CEO, Richard M. Scrushy, who was accused of directing company employees to falsely report company earnings to meet stockholder expectations.
Financials
Quarterly financials
(USD)Dec 2023Q/Q
Revenue1.2B+3%
Operating Income164.8MM+14%
Operating Expenses1.1B-
Net Income87.6MM+3%
G&A53.1MM+7%
Compensation676.3MM+3%
Interest Expense34.9MM-3%
Stock Chart

Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from 

Finra

Moving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.

Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.

Stock news

    Investing in defensive stocks like ResMed Inc. (RMD), Encompass Health Corporation (EHC), New Jersey Resources Corporation (NJR) and Global Water Resources, Inc. (GWRS) would be a wise idea during these times of uncertainty.

    Encompass Health Corporation (NYSE: EHC) today announced that its board of directors has declared a quarterly cash dividend on its common stock of $0.15 per share, payable on July 15, 2024, to holders of record on July 1, 2024.

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

    On May 1, Encompass Health opened its call for research grant applications due Sept. 30 at 5 p.m. CST. The grants, totaling up to $50,000, will be awarded for the investigation of the impact or effectiveness of therapies in the inpatient rehabilitation facility post-acute care setting, knowledge translation or implementation science. Grant recipients do not have to be affiliated with Encompass Health and research does not have to be conducted in an Encompass Health inpatient rehabilitation hospi

    EHC vs. CHE: Which Stock Is the Better Value Option?

    Teladoc Health's (TDOC) Q1 results suffer from weak contributions from the BetterHelp unit. Management expects U.S. Integrated Care Members of 92-94 million for 2024, up from the prior mentioned 90-92 million.

    Encompass Health Corporation (NYSE:EHC) Q1 2024 Earnings Call Transcript April 25, 2024 Encompass Health Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, everyone, and welcome to Encompass Health’s First Quarter 2024 Earnings Conference Call. [Operator Instructions] Today’s […]

    The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

    Encompass Health (EHC) increases its guidance for net operating revenues, which is in the range of $5.25-$5.325 million for 2024.

    Amedisys (AMED) tops on revenue and earnings estimates in the first quarter of fiscal 2024.